Suber Huang, MD
Retina Specialist · Cleveland, OHNPI 1598781395
Payments from drug & device makers
What this record shows
This record is dominated by grants: $100,000 of the $123,729 with a category attached, or 80.8%. Bausch & Lomb Americas Inc. accounts for 80.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $100,716 and has fallen 93.6% since, to $6,428 in 2025. Among retina specialist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $1903.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$100K
- Cortigent Inc$13K
- Alcon$6K
- Nidek CO., LTD.$2K
- Novo Nordisk AS$2K
- Apellis Pharmaceuticals, Inc.$336
- plus $934 from 12 others
Across 2 payments — averaging $2019.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$4K
What the payments were for
- Consulting fees$12,60010%
- Speaking & faculty fees$2,0002%
- Grants$100,00081%
- Travel & lodging$9911%
- Food & beverage$1,8221%
- Other$6,3175%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 3 | $100,026 |
| Cortigent Inc | 13 | $12,600 |
| Alcon | 1 | $6,317 |
| Nidek CO., LTD. | 1 | $2,000 |
| Novo Nordisk AS | 4 | $1,516 |
| Apellis Pharmaceuticals, Inc. | 10 | $336 |
| AbbVie | 6 | $183 |
| Dutch Ophthalmic, USA | 1 | $172 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Alimera Sciences, Inc. | 7 | $111 |
| Genentech USA, Inc. | 4 | $89 |
| Astellas Pharma US Inc | 3 | $75 |
| Regeneron | 1 | $57 |
| Genentech, Inc. | 1 | $30 |
| Eyepoint US, Inc. | 1 | $26 |
| Coherus Oncology, Inc. | 1 | $24 |
| Novartis | 1 | $17 |
| Spark Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Argus II Retinal Prosthesis System$4,800
- Orion$3,750
- Argus II$2,850
- Mirante$2,000
- Orion Visual Cortical Prosthesis$1,200
- EVA, combined machine$172
- TISSUEBLUE$172
How this compares
$123,729 in reported general payments places this provider in the 90th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 260 | $2,354 |
| Timolol Maleate | 160 | $2,285 |
| Prednisolone Acetate | 28 | $1,466 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 17 | $763 |
| Brimonidine Tartrate | 39 | $486 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $424 |
| Dorzolamide Hcl | 27 | $374 |
| Diclofenac Sodium | 13 | $82 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Cleveland
- Sumit SharmaCleveland$428K
- Aleksandra RachitskayaCleveland$303K
- Katherine TalcottCleveland$272K
- Ananth SastryCleveland$44K
- Phoebe LinCleveland$22K
- Warren SobolCleveland$5K
- Mark SeralyCleveland$3K
- Abhishek NaiduCleveland$3K
- Mary-Grace ReevesCleveland$2K
- Joseph ConeyBeachwood$980K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.